Clinical trials
Adenoma, Islet Cell trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
59 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 2 |
| 2001 | 2 |
| 2002 | 1 |
| 2003 | 1 |
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2008 | 4 |
| 2009 | 2 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 3 |
| 2015 | 3 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 28 |
| Recruiting | 11 |
| Active, not recruiting | 7 |
| Terminated | 5 |
| Unknown status | 2 |
| Withdrawn | 2 |
| Enrolling by invitation | 1 |
| Suspended | 1 |
| No longer available | 1 |
| Available | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Dana-Farber Cancer Institute | 5 |
| National Cancer Institute (NCI) | 3 |
| National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | 3 |
| H. Lee Moffitt Cancer Center and Research Institute | 2 |
| M.D. Anderson Cancer Center | 2 |
| Novartis Pharmaceuticals | 2 |
| Ohio State University Comprehensive Cancer Center | 2 |
| RayzeBio, Inc. | 2 |
| Rezolute | 2 |
| Roswell Park Cancer Institute | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Adenoma, Islet Cell | 59 |
| Neuroendocrine Tumors | 20 |
| Insulinoma | 14 |
| Carcinoma, Islet Cell | 12 |
| Somatostatinoma | 12 |
| Carcinoid Tumor | 11 |
| Gastrinoma | 11 |
| Glucagonoma | 10 |
| Neoplasm Metastasis | 9 |
| Neoplasms | 9 |
Trials
Showing 1 to 25 of 59. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.